What does Celldex Therapeutics, Inc. do?
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which…
What is Celldex Therapeutics, Inc.'s P/E and P/B ratio?
Celldex Therapeutics, Inc. has a P/E ratio of -6.7 and a P/B ratio of 3.18.
What is Celldex Therapeutics, Inc.'s debt-to-equity ratio?
Celldex Therapeutics, Inc. has a debt-to-equity ratio of 0.01.
How much does Celldex Therapeutics, Inc. owe compared with what it owns?
Celldex Therapeutics, Inc. owes $0.09 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Celldex Therapeutics, Inc.'s Positivity rank?
Celldex Therapeutics, Inc. is ranked #4,626 of 6,774 companies globally and #2,365 of 4,000 in United States on PositoAI, with a Positivity Score of 19,197.
Does Celldex Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Celldex Therapeutics, Inc..
Where can I read the latest news about Celldex Therapeutics, Inc.?
Recent headlines about Celldex Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Celldex Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Celldex Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.